05-14 Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
03-30 Venmax Drugs and Pharmaceuticals Limited Announces Appointment of Mrs. Padmaja Kalyani Sadhanala as Additional Directorr, Effective March 30, 2026 CI
02-07 Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
11-24 Venmax Drugs and Pharmaceuticals Limited Announces Resignation of Dakshita Jain as Non-Executive Independent Director, Effective November 24, 2025 CI
11-12 Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
25-09-29 Venmax Drugs and Pharmaceuticals Limited Approves Regularization of Additional Dakshita Jain as Non-Executive Independent Director CI
25-09-02 Venmax Drugs and Pharmaceuticals Limited Announces Resignation of Pilli Meena Kumari as Non-Executive Independent Director, with Effect from 2Nd September 2025 CI
25-08-24 Venmax Drugs and Pharmaceuticals Limited agreed to acquire Hatri Pharma Private Limited. CI
25-07-23 Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
25-05-09 Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2025 CI
25-03-19 Venmax Drugs and Pharmaceuticals Limited announced that it has received INR 50.125 million in funding from White Saffron Grains LLP, Mega Flex Plastics Limited, Channel Plastics Private Limited, Wca Services Private Limited CI
25-02-08 Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024 CI
24-12-27 Venmax Drugs and Pharmaceuticals Limited Announces Cessation of Nooka Krishnaiah as Member Nomination and Remuneration Committee CI
Manager TitleAgeSince
Chief Executive Officer 62 2026-03-10
Director of Finance/CFO - -
Compliance Officer - -
Director TitleAgeSince
Director/Board Member - 2024-01-15
Director/Board Member 37 2022-07-31
Director/Board Member 43 2024-08-21
Change 5-day change 1-year change 3-year change Capi.($)
-0.71%+4.24% - - 1.98M
+0.85%-0.80%+54.84%+163.70% 1,051B
+1.23%-1.53%+55.26%+59.07% 609B
+0.04%+2.58%+32.96%+88.75% 450B
+0.78%-0.71%+30.04%+24.61% 330B
+1.41%+0.58%+33.92%+47.20% 284B
-0.27%-1.87%+22.13%+23.47% 263B
-1.76%+2.37%-22.19%-38.45% 223B
-1.42%+0.80%+22.81%+60.77% 198B
-1.48%+3.43%+23.42%+73.31% 167B
Average -0.18%+0.54%+28.13%+55.82% 397.23B
Weighted average by Cap. +0.22%+0.02%+37.75%+81.49%
  1. Stock Market
  2. Stocks
  3. 531015 Stock